Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Metastatic colorectal cancer
Page 1 of 1 ( 35 items )
<<
1
>>
1
Evaluation of efficacy and safety of targeted therapy and immune checkpoint inhibitors in metastatic colorectal cancer
5/15/2025 10:28:57 AM |
Browse: 12 |
Download: 16
2
Overall survival with frontline vs subsequent anti-epidermal growth factor receptor therapies in unresectable, RAS/BRAF wild-type, left-sided metastatic colorectal cancer
1/21/2025 9:22:10 AM |
Browse: 31 |
Download: 62
3
Cohort study on the treatment of BRAF V600E mutant metastatic colorectal cancer with integrated Chinese and western medicine
10/30/2024 10:05:59 AM |
Browse: 35 |
Download: 156
4
Successful cetuximab rechallenge in metastatic colorectal cancer: A case report
8/29/2024 8:28:55 AM |
Browse: 73 |
Download: 204
5
Therapeutic strategies for targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer
6/15/2024 2:49:03 AM |
Browse: 57 |
Download: 227
6
Emerging role of liquid biopsy in rat sarcoma virus mutated metastatic colorectal cancer: A case report
1/11/2024 6:17:31 AM |
Browse: 184 |
Download: 495
7
Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen (CA) 125, CA199 analysis
1/2/2024 9:08:46 AM |
Browse: 160 |
Download: 616
8
Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
10/24/2023 7:40:42 AM |
Browse: 219 |
Download: 588
9
Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
1/22/2022 6:41:14 AM |
Browse: 513 |
Download: 1156
10
Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy
1/15/2022 12:57:35 PM |
Browse: 330 |
Download: 1062
11
New drugs for the treatment of metastatic colorectal cancer
11/12/2021 11:22:24 AM |
Browse: 508 |
Download: 1012
12
Prognostic role of sarcopenia in metastatic colorectal cancer patients during first line chemotherapy: A retrospective study
5/22/2021 10:39:22 AM |
Browse: 604 |
Download: 1562
13
Chemotherapy rechallenge in metastatic colon cancer: A case report
11/18/2020 2:20:37 PM |
Browse: 637 |
Download: 795
14
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
10/14/2020 1:53:47 PM |
Browse: 591 |
Download: 1160
15
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
12/28/2019 9:29:28 AM |
Browse: 830 |
Download: 1639
16
Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
11/15/2019 7:45:48 AM |
Browse: 915 |
Download: 2023
17
Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer
8/7/2019 7:09:17 AM |
Browse: 834 |
Download: 1654
18
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
7/12/2017 6:45:23 AM |
Browse: 1111 |
Download: 1893
19
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM |
Browse: 1112 |
Download: 1709
20
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
8/4/2016 5:58:00 PM |
Browse: 1042 |
Download: 1434
21
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
7/22/2016 1:36:00 PM |
Browse: 1203 |
Download: 1634
22
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM |
Browse: 1283 |
Download: 1890
23
Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy
4/19/2016 9:45:00 AM |
Browse: 991 |
Download: 2002
24
Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients
2/2/2016 6:35:00 PM |
Browse: 1059 |
Download: 1462
25
Novel therapeutic agents in the treatment of metastatic colorectal cancer
1/14/2016 8:16:00 PM |
Browse: 1104 |
Download: 1316
26
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
11/24/2015 3:55:00 PM |
Browse: 1201 |
Download: 1585
27
Anti-angiogenic agents in metastatic colorectal cancer
7/14/2015 12:20:00 PM |
Browse: 890 |
Download: 1622
28
Standard chemotherapy with cetuximab for treatment of colorectal cancer
6/18/2015 5:31:00 PM |
Browse: 1095 |
Download: 1407
29
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM |
Browse: 1099 |
Download: 1507
30
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM |
Browse: 1190 |
Download: 1557
31
Sequencing of treatment in metastatic colorectal cancer: Where to fit the target?
9/2/2014 3:20:00 PM |
Browse: 900 |
Download: 881
32
Role of cetuximab in first-line treatment of metastatic colorectal cancer
8/29/2014 11:31:00 AM |
Browse: 1113 |
Download: 1250
33
Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?
8/26/2014 5:16:00 PM |
Browse: 1069 |
Download: 1504
34
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
8/25/2014 2:47:00 PM |
Browse: 984 |
Download: 858
35
Personalizing medicine for metastatic colorectal cancer: Current developments
8/18/2014 5:14:00 PM |
Browse: 1208 |
Download: 1205
Page 1 of 1 ( 35 items )
<<
1
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345